---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-024947"
form_type: "8-K"
ticker: "NRC"
cik: "0000070487"
company_name: "NRC HEALTH"
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:45:17.939617+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# NRC Health Q2 revenue $35M, EPS $0.26; amends credit; acquires NOBL Health

## Summary
- Q2 revenue ~$35M vs ~$36M YoY; diluted EPS $0.26 vs $0.29 YoY; TRCV $138M at June 30.
- Credit agreement amended: maturity extended to May 2027; term loans bear SOFR+2.35% with 10-year amort.
- Acquired NOBL Health on July 15 for ~$6M cash + up to $1M earnout; NOBL had ~$2M TRCV.
- Board declared $0.12/share quarterly dividend, payable Oct 11, record Sep 27.
- ~1.1M shares remain under repurchase plan; no buybacks in Q2 pending amendment.

## SEC filing metadata
- accession: 0001437749-24-024947
- form_type: 8-K
- ticker: NRC
- cik: 0000070487
- company_name: NRC HEALTH
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70487/000143774924024947/0001437749-24-024947-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70487/000143774924024947/nrc20240806_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-024947
- JSON: https://secwatch.observer/filing/0001437749-24-024947.json
- Plain text: https://secwatch.observer/filing/0001437749-24-024947.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.